Learn More
ITGB1 Monoclonal Antibody (4B7R), Invitrogen™
Description
MA5-13658 targets CD29 in FACS, IF, and IHC (F) applications and shows reactivity with Human and Porcine samples. The MA5-13658 immunogen is human melanoma V+B2 cell line.
Specifications
Specifications
| Antigen | ITGB1 |
| Applications | Immunocytochemistry, Immunohistochemistry (Frozen) |
| Classification | Monoclonal |
| Clone | 4B7R |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 |
| Gene | ITGB1 |
| Gene Accession No. | P05556, Q9GLP0 |
| Gene Alias | 4633401G24Rik; AA409975; AA960159; Beta OL; beta oligodendroglia; CD29; CSAT antigen; ENSMUSG00000051907; Fibronectin receptor subunit beta; FNRB; Glycoprotein IIa; Gm9863; gpIIa; integrin beta 1; integrin beta 1 (fibronectin receptor beta); integrin beta 1A precursor; Integrin beta1; integrin beta-1; integrin beta-1 subunit; integrin beta1D; integrin precursor; integrin subunit beta 1; integrin VLA-4 beta subunit; integrin VLA-4 subunit beta; integrin, beta 1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); ITBG1D; ITGB1; JG22 antigen; MDF2; MSK12; RGD-receptor; very late activation protein, beta polypeptide; VLA-4 subunit beta; VLAB; VLA-BETA |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.